Global /United States /Healthcare /Diagnostics & Research /950130
chevron_leftBack

Access Bio, Inc.

950130
KRX: 950130 Delayed
5,060KRW 0.4%
3.54 USD
As of 24 April 2025, Access Bio, Inc. has a market cap of $123.99M USD, ranking #19555 globally and #3223 in the United States. It ranks #1948 in the Healthcare sector, and #97 in the Diagnostics & Research industry.
Global Rank
19555
Country Rank
3223
Sector Rank
1948
Industry Rank
97
Key Stats
Market Cap
$123.99MUSD
177.98B KRW
Enterprise Value
-$146.14MUSD
-208.61B KRW
Revenue (TTM)
$78.35MUSD
112.46B KRW
EBITDA (TTM)
$5.24MUSD
7.48B KRW
Net Income (TTM)
-$242.13KUSD
-347.58M KRW
EBITDA Margin
6.6%
Profit Margin
-0.3%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Young-Ho Choi open_in_new
Employees
101
Founded
2002
Website
accessbio.net open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.4% 3.6% 1.3% -14% -18% -22%
Upcoming Earnings
Earnings Date
Tue, May 13

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
950130
Access Bio Inc Korean Depository Receipts
ISIN: KR8840090003
Shares Out.:
37.728M1 Shares Float: 28.498M2
TV:
SA:
YF:
GF:
BA:
MS:
5.06K KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Access Bio, Inc.

Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources; analyzers, designed to measure different chemicals and other characteristics in biological samples; and molecular diagnostic solutions used in analyzing biological markers in the genome and proteome. It offers its products under CareStart, CareUS, CareSURE, and CareGENE brand names. The company was incorporated in 2002 and is headquartered in Somerset, New Jersey.

Similar Companies

Industry: Diagnostics & Research (United States)
Name
Market Cap diff.
Thermo Fisher Scientific Inc.
TMO
$162.94B
131K%
Danaher Corp.
DHR
$140.49B
113K%
IDEXX Laboratories, Inc.
IDXX
$34.57B
28K%
Agilent Technologies, Inc.
A
$29.94B
24K%
IQVIA Holdings Inc.
IQV
$25.93B
21K%
Industry: Diagnostics & Research (Global)
Name
Market Cap diff.
Lonza Group AG
LONN
$46.75B
38.79B CHF
38K%
WuXi AppTec Co., Ltd.
603259
$22.16B
161.5B CNY
18K%
bioMérieux S.A.
BIM
$15.23B
13.39B EUR
12K%
ICON Public Limited Co.
ICLR
$11.56B
9K%
Eurofins Scientific SE
ERF
$11.46B
10.07B EUR
9K%